Feasibility of the IC-Flow Device for Fluorescent Perfusion Evaluation During Feasibility of the IC-Flow Device
Completed
Conditions studied: Skin Flap Necrosis, Perfusion; Complications
In brief
1. Primary Objective: Demonstrate that the IC-Flow Imaging device with Indocyanine Green (ICG) is a feasible technique when visualizing and identifying perfusion of organs when compared to The KARL STORZ VITOM II ICG System during open reconstructive surgical procedures 2. Secondary Objective: 1. Evaluate the mean Assessment of handling properties using The IC- Flow versus The VITOM II. 2. Evaluate the mean Surgeon preference Level using The IC- Flow tower, The IC-Flow Hand-held device versus The VITOM II.
Key facts
- Study ID
- NCT03860493
- Run by
- The Cleveland Clinic
- People needed
- 6
- Starts
- 2019-05-15
- Expected to finish
- 2020-12-31
- Last updated by the study team
- 2021-02-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients of both genders
- Minimum age: 18 years old
- Spoken and written command of the language spoken in the country's center
- Ability to understand and follow the study procedures and sign the informed consent
- open surgical porcedures
You may not qualify if…
- Known allergies to iodides
- Known history of coagulopathy
- Women who are pregnant or breastfeeding, or for whom possibility of pregnancy was not ruled out
Where it is running
- Cleveland Clinic Florida — Weston, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.